HUE026542T2 - Gyermekkori gyulladásos bélbetegség lókuszok azonosítása és eljárások ezek alkalmazásával gyermekkori gyulladásos bélbetegség diagnosztizálására és kezelésére - Google Patents

Gyermekkori gyulladásos bélbetegség lókuszok azonosítása és eljárások ezek alkalmazásával gyermekkori gyulladásos bélbetegség diagnosztizálására és kezelésére

Info

Publication number
HUE026542T2
HUE026542T2 HUE09712711A HUE09712711A HUE026542T2 HU E026542 T2 HUE026542 T2 HU E026542T2 HU E09712711 A HUE09712711 A HU E09712711A HU E09712711 A HUE09712711 A HU E09712711A HU E026542 T2 HUE026542 T2 HU E026542T2
Authority
HU
Hungary
Prior art keywords
diagnosis
identification
treatment
methods
same
Prior art date
Application number
HUE09712711A
Other languages
English (en)
Inventor
Hakon Hakonarson
Jonathan Bradfield
Marcin Imielinski
Struan Grant
Original Assignee
The Children's Hospital Of Philadelphia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Children's Hospital Of Philadelphia filed Critical The Children's Hospital Of Philadelphia
Publication of HUE026542T2 publication Critical patent/HUE026542T2/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/136Screening for pharmacological compounds
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/172Haplotypes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medical Treatment And Welfare Office Work (AREA)
HUE09712711A 2008-02-19 2009-02-19 Gyermekkori gyulladásos bélbetegség lókuszok azonosítása és eljárások ezek alkalmazásával gyermekkori gyulladásos bélbetegség diagnosztizálására és kezelésére HUE026542T2 (hu)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2984108P 2008-02-19 2008-02-19
US5948608P 2008-06-06 2008-06-06

Publications (1)

Publication Number Publication Date
HUE026542T2 true HUE026542T2 (hu) 2016-06-28

Family

ID=40986189

Family Applications (1)

Application Number Title Priority Date Filing Date
HUE09712711A HUE026542T2 (hu) 2008-02-19 2009-02-19 Gyermekkori gyulladásos bélbetegség lókuszok azonosítása és eljárások ezek alkalmazásával gyermekkori gyulladásos bélbetegség diagnosztizálására és kezelésére

Country Status (9)

Country Link
US (3) US20110177502A1 (hu)
EP (1) EP2257643B1 (hu)
AU (1) AU2009215441B2 (hu)
CA (1) CA2714713C (hu)
DK (1) DK2257643T3 (hu)
HR (1) HRP20150684T1 (hu)
HU (1) HUE026542T2 (hu)
SI (1) SI2257643T1 (hu)
WO (1) WO2009105590A2 (hu)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100240043A1 (en) * 2007-10-19 2010-09-23 Cedars-Sinai Medical Center Methods of using genetic variants to diagnose and predict inflammatory bowel disease
JP2011509071A (ja) * 2007-11-29 2011-03-24 ジェネンテック, インコーポレイテッド 炎症性腸疾患のための遺伝子発現マーカー
WO2010062960A2 (en) 2008-11-26 2010-06-03 Cedars-Sinai Medical Center METHODS OF DETERMINING RESPONSIVENESS TO ANTI-TNFα THERAPY IN INFLAMMATORY BOWEL DISEASE
CA2801575A1 (en) * 2010-06-04 2011-12-08 Prometheus Laboratories Inc. Methods for improving inflammatory bowel disease diagnosis
CN105246501B (zh) 2013-03-27 2021-01-12 雪松-西奈医学中心 通过抑制tl1a的功能和相关信号传导途径来减轻并逆转纤维化和炎症
KR20210107176A (ko) * 2013-05-17 2021-08-31 세다르스-신나이 메디칼 센터 크론병과 연관된 tnfsf15와 dcr3의 변이체
EP3022295A4 (en) 2013-07-19 2017-03-01 Cedars-Sinai Medical Center Signature of tl1a (tnfsf15) signaling pathway
CN113604543A (zh) 2014-03-27 2021-11-05 豪夫迈·罗氏有限公司 用于诊断和治疗炎症性肠病的方法
US10407725B2 (en) 2015-08-21 2019-09-10 The Children's Hospital Of Philadelphia Methods of treating autoimmune conditions in patients with genetic variations in DcR3 or in a DcR3 network gene
EP3430172A4 (en) 2016-03-17 2019-08-21 Cedars-Sinai Medical Center METHOD FOR DIAGNOSIS OF INFLAMMATORY ENDURANCE THROUGH RNASET2
WO2022201181A1 (en) * 2021-03-24 2022-09-29 Indian Council Of Medical Research RT-LAMP ASSAY FOR DETECTION OF HUMAN β-ACTIN HOUSEKEEPING GENE

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ207394A (en) 1983-03-08 1987-03-06 Commw Serum Lab Commission Detecting or determining sequence of amino acids
EP0647268B1 (en) 1990-06-15 2004-03-03 Scios Inc. Transgenic non-human mammal displaying the amyloid-forming pathology of alzheimer's disease
WO1993014200A1 (en) 1992-01-07 1993-07-22 Tsi Corporation Transgenic animal models for alzheimer's disease
US5604102A (en) 1992-04-15 1997-02-18 Athena Neurosciences, Inc. Methods of screening for β-amyloid peptide production inhibitors
GB9212416D0 (en) 1992-06-11 1992-07-22 Medical Res Council Reversible binding substances
US5877399A (en) 1994-01-27 1999-03-02 Johns Hopkins University Transgenic mice expressing APP-Swedish mutation develop progressive neurologic disease
US5849999A (en) 1996-10-16 1998-12-15 The Mclean Hospital Corporation Transgenic non-human mice expressing Flag-APP-C100 protein develop alzheimer's disease brain morphology and behavior
US6057098A (en) 1997-04-04 2000-05-02 Biosite Diagnostics, Inc. Polyvalent display libraries
WO2007073478A2 (en) * 2005-12-19 2007-06-28 Genizon Biosciences Inc. Genemap of the human genes associated with crohn's disease

Also Published As

Publication number Publication date
CA2714713A1 (en) 2009-08-27
US20110177502A1 (en) 2011-07-21
EP2257643B1 (en) 2015-04-08
HRP20150684T1 (hr) 2015-09-11
AU2009215441B2 (en) 2015-07-02
CA2714713C (en) 2018-02-27
US20190218612A1 (en) 2019-07-18
US11111539B2 (en) 2021-09-07
EP2257643A4 (en) 2012-08-22
SI2257643T1 (sl) 2018-12-31
EP2257643A2 (en) 2010-12-08
AU2009215441A1 (en) 2009-08-27
US20220056529A1 (en) 2022-02-24
WO2009105590A2 (en) 2009-08-27
DK2257643T3 (en) 2015-06-29
WO2009105590A3 (en) 2010-01-07

Similar Documents

Publication Publication Date Title
SI2257643T1 (sl) Identifikacija predelov vnetne črevesne bolezni z začetkom v otroštvu in metode za njeno uporabo za diagnozo in zdravljenje te bolezni
IL225519A0 (en) Effective preparations and methods for the treatment and diagnosis of inflammatory bowel disease
HK1158705A1 (zh) 微泡在醫學疾病和病況的診斷、預後以及治療中的用途
BRPI0908026A2 (pt) Métodos para o tratamento de doenças do intestino
SI2104682T1 (sl) Diagnostika in zdravljenje Alzheimerjeve bolezni in drugih nevrodementnih bolezni
IL207360A0 (en) Methods of diagnosing and treating parp - mediated diseases
EP2178455A4 (en) TREATMENT DEVICE FOR LIVING TISSUE
EP2041317A4 (en) METHODS AND COMPOSITIONS BASED ON MICRO-RNA FOR THE DIAGNOSIS AND TREATMENT OF COLON CANCER RELATED DISEASES
EP1949844A4 (en) ENDOSCOPIC DIAGNOSTIC METHOD OR THERAPEUTIC AND MEDICAL DEVICE
IL200549A0 (en) 2 -substituted- 3 -phenylpropionic acid derivatives and their use in the treatment of inflammatory bowel disease
PT2614832T (pt) Diagnóstico de pré-eclâmpsia
HK1169455A1 (zh) 阿爾茨海默病的診斷和治療
EP2459510A4 (en) HYDROXIDE-FATTY ACID COMPOSITIONS AND USES THEREOF FOR ILLNESS TREATMENT AND DIAGNOSIS
GB0608647D0 (en) Methods of diagnosis and treatment
EP1869212A4 (en) USE OF ID4 FOR DIAGNOSIS AND TREATMENT OF CANCER
HK1145316A1 (zh) 用於中樞神經系統疾病或腫瘤的成像、診斷和/或治療的化合物
EP2051732A4 (en) DIAGNOSIS AND TREATMENT OF METABOLIC DISORDERS AND METHODS THEREFOR
HK1221905A1 (zh) 作爲用於炎性腸病和/或腸易激綜合征的治療的應用
EP2134863A4 (en) GENETIC MODIFICATIONS ON CHROMOSOME 16 AND METHODS OF USING THE SAME FOR THE DIAGNOSIS AND TREATMENT OF TYPE I DIABETES
IL213703A0 (en) Compounds and methods for the treatment of pain and other diseases
PL2234631T3 (pl) Związki i metody stosowane w terapii choroby naczyniowej
GB2465907B (en) VHZ for diagnosis and treatment of cancer
HK1203190A1 (en) Compounds for use in imaging, diagnosing and or treatment of diseases of the central nervous system
GB0709092D0 (en) Diagnosis and method of disease
EP2361317A4 (en) USE OF EIF3M FOR THE DIAGNOSIS AND TREATMENT OF CANCER